A Study of the Incidence of Intraocular Inflammation and Suspected Endophthalmitis Among Patients Treated With Aflibercept, Vial and Pre-filled Syringe, 2014-2022

Clinical trial NCT05791695 · COMPLETED

Trial details

NCT number: NCT05791695
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Intraocular Inflammation Suspected Endophthalmitis

Start date: 2022-09-16
Primary completion: 2022-12-30
Enrollment: 155413

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.